Olanzapine induced neuroleptic malignant syndrome

被引：30

作者：

Burkhard, PR ^{[1
]}

Vingerhoets, FJG ^{[1
]}

机构：

[1] Univ Hosp Geneva, Dept Neurol, CH-1211 Geneva 14, Switzerland

来源：

ARCHIVES OF GENERAL PSYCHIATRY | 1999年 / 56卷 / 01期

关键词：

D O I：

10.1001/archpsyc.56.1.101

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：101 / 102

页数：2

共 7 条

[1] NEUROLEPTIC MALIGNANT SYNDROME [J].

CAROFF, SN ;

MANN, SC .

MEDICAL CLINICS OF NORTH AMERICA, 1993, 77 (01) :185-202

[2] Olanzapine - A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses [J].

Fulton, B ;

Goa, KL .

DRUGS, 1997, 53 (02) :281-298

[3] Olanzapine in treatment-refractory schizophrenia: Results of an open-label study [J].

Martin, J ;

Gomez, JC ;

GarciaBernardo, E ;

Cuesta, M ;

Alvarez, E ;

Gurpegui, M .

JOURNAL OF CLINICAL PSYCHIATRY, 1997, 58 (11) :479-483

[4]

Nopoulos P, 1990, ANN CLIN PSYCHIATRY, V2, P251, DOI DOI 10.3109/10401239009147953

[5] APPARENT NEUROLEPTIC MALIGNANT SYNDROME WITH CLOZAPINE AND LITHIUM [J].

POPE, HG ;

COLE, JO ;

CHORAS, PT ;

FULWILER, CE .

JOURNAL OF NERVOUS AND MENTAL DISEASE, 1986, 174 (08) :493-495

[6] CLOZAPINE-INDUCED NEUROLEPTIC MALIGNANT SYNDROME - REVIEW AND REPORT OF NEW CASES [J].

SACHDEV, P ;

KRUK, J ;

KNEEBONE, M ;

KISSANE, D .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (05) :365-371

[7] Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia [J].

Tran, PV ;

Dellva, MA ;

Tollefson, GD ;

Beasley, CM ;

Potvin, JH ;

Kiesler, GM .

JOURNAL OF CLINICAL PSYCHIATRY, 1997, 58 (05) :205-211

← 1 →